Lombard Odier Asset Management (Switzerland)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.3M | Sell |
30,569
-4,533
| -13% | -$246K | 0.04% | 283 |
|
|
2026
Q1 | $2.2M | Sell |
35,102
-18,562
| -35% | -$1.48M | 0.08% | 200 |
|
|
2025
Q4 | $5.12M | Sell |
53,664
-39,803
| -43% | -$3.9M | 0.22% | 99 |
|
|
2025
Q3 | $9.13M | Buy |
93,467
+24,940
| +36% | +$2.58M | 0.41% | 49 |
|
|
2025
Q2 | $7.36M | Buy |
68,527
+11,159
| +19% | +$1.13M | 0.37% | 60 |
|
|
2025
Q1 | $5.79M | Buy |
57,368
+6,154
| +12% | +$620K | 0.33% | 71 |
|
|
2024
Q4 | $4.57M | Buy |
51,214
+4,588
| +10% | +$404K | 0.34% | 72 |
|
|
2024
Q3 | $3.91M | Buy |
46,626
+1,662
| +4% | +$131K | 0.33% | 85 |
|
|
2024
Q2 | $3.46M | Sell |
44,964
-475
| -1% | -$34.8K | 0.35% | 75 |
|
|
2024
Q1 | $3.11M | Buy |
+45,439
| New | +$2.92M | 0.22% | 117 |
|
|
2023
Q2 | – | Sell |
-6,834
| Closed | -$342K | – | 181 |
|
|
2023
Q1 | $342K | Buy |
6,834
+663
| +11% | +$31.2K | 0.03% | 323 |
|
|
2022
Q4 | $286K | Buy |
+6,171
| New | +$267K | 0.02% | 334 |
|
|
2022
Q3 | – | Sell |
-7,221
| Closed | -$269K | – | 286 |
|
|
2022
Q2 | $269K | Sell |
7,221
-3,330
| -32% | -$136K | 0.02% | 281 |
|
|
2022
Q1 | $467K | Hold |
10,551
| – | – | 0.04% | 149 |
|
|
2021
Q4 | $448K | Sell |
10,551
-7,645
| -42% | -$321K | 0.03% | 257 |
|
|
2021
Q3 | $737K | Buy |
18,196
+1,953
| +12% | +$86.4K | 0.05% | 171 |
|
|
2021
Q2 | $695K | Buy |
16,243
+2,191
| +16% | +$92.2K | 0.04% | 264 |
|
|
2021
Q1 | $543K | Sell |
14,052
-6,450
| -31% | -$244K | 0.04% | 232 |
|
|
2020
Q4 | $737K | Buy |
20,502
+10,399
| +103% | +$375K | 0.08% | 95 |
|
|
2020
Q3 | $386K | Buy |
+10,103
| New | +$389K | 0.04% | 272 |
|
|
2020
Q2 | – | Sell |
-424,321
| Closed | -$13.8M | – | 179 |
|
|
2020
Q1 | $13.8M | Hold |
424,321
| – | – | 1.85% | 17 |
|
|
2019
Q4 | $19.2M | Hold |
424,321
| – | – | 1.8% | 12 |
|
|
2019
Q3 | $17.3M | Hold |
424,321
| – | – | 1.86% | 14 |
|
|
2019
Q2 | $18.2M | Buy |
424,321
+320,000
| +307% | +$12.3M | 1.85% | 13 |
|
|
2019
Q1 | $4M | Sell |
104,321
-150,000
| -59% | -$5.73M | 0.41% | 50 |
|
|
2018
Q4 | $8.99M | Sell |
254,321
-122,667
| -33% | -$4.45M | 1.02% | 29 |
|
|
2018
Q3 | $14.5M | Buy |
376,988
+47,667
| +14% | +$1.66M | 1.44% | 21 |
|
|
2018
Q2 | $10.8M | Buy |
+329,321
| New | +$9.93M | 1.13% | 23 |
|
|
2017
Q3 | – | Sell |
-34,321
| Closed | -$951K | – | 358 |
|
|
2017
Q2 | $951K | Sell |
34,321
-211,778
| -86% | -$5.62M | 0.11% | 188 |
|
|
2017
Q1 | $6.12M | Sell |
246,099
-13,901
| -5% | -$338K | 0.68% | 38 |
|
|
2016
Q4 | $5.62M | Sell |
260,000
-140,000
| -35% | -$3.05M | 1.42% | 23 |
|
|
2016
Q3 | $9.52M | Hold |
400,000
| – | – | 2.27% | 20 |
|
|
2016
Q2 | $9.35M | Sell |
400,000
-100,000
| -20% | -$2.16M | 1.27% | 24 |
|
|
2016
Q1 | $9.4M | Buy |
500,000
+445,270
| +814% | +$7.82M | 1.12% | 25 |
|
|
2015
Q4 | $1.01M | Buy |
+54,730
| New | +$981K | 0.12% | 104 |
|
|
2015
Q3 | – | Sell |
-27,802
| Closed | -$492K | – | 297 |
|
|
2015
Q2 | $492K | Sell |
27,802
-7,672
| -22% | -$137K | 0.04% | 340 |
|
|
2015
Q1 | $635K | Buy |
+35,474
| New | +$561K | 0.07% | 273 |
|
|
2014
Q4 | – | Sell |
-118,501
| Closed | -$1.41M | – | 440 |
|
|
2014
Q3 | $1.41M | Buy |
118,501
+117,713
| +14,938% | +$1.48M | 0.04% | 447 |
|
|
2014
Q2 | $10K | Buy |
+788
| New | +$10.2K | ﹤0.01% | 570 |
|
Other funds holding BSX
Lombard Odier Asset Management (Switzerland)'s BSX Position: Q2 2026 in Review
Lombard Odier Asset Management (Switzerland) reduced its Boston Scientific (BSX) stake by 13% in Q2 2026, selling an estimated $246K and leaving 30,569 shares worth $1.3M. The position accounts for 0.04% of the portfolio, ranked #283.
Lombard Odier Asset Management (Switzerland) first reported a position in BSX in Q2 2014 and has held it in 39 quarters since. The position peaked at $19.2M in Q4 2019. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Lombard Odier Asset Management (Switzerland) held 30,569 shares of Boston Scientific worth $1.3M as of Q2 2026.
- Lombard Odier Asset Management (Switzerland) sold 4,533 Boston Scientific shares in Q2 2026, an estimated $246K.
- Boston Scientific made up 0.04% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q2 2026, its #283 holding.
- Lombard Odier Asset Management (Switzerland) first reported a position in Boston Scientific in Q2 2014 and has held it in 39 quarters since.
- Lombard Odier Asset Management (Switzerland)'s Boston Scientific position peaked at $19.2M in Q4 2019.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2026, filed 14 Aug 2026.